tradingkey.logo
tradingkey.logo
Buscar

ASP Isotopes Inc

ASPI
Añadir a la lista de seguimiento
3.040USD
-0.205-6.32%
Cierre 09-18 16:00ET
395.65MCap. mercado
PérdidaP/E TTM
Fuera de horario 19:33 (ET)3.070USD+0.015+0.49%

Más Datos de ASP Isotopes Inc Compañía

ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.

Perfil de ASP Isotopes Inc

Símbolo de cotizaciónASPI
Nombre de la empresaASP Isotopes Inc
Fecha de salida a bolsaNov 10, 2022
Director ejecutivoAinscow (Robert)
Número de empleados136
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 10
Dirección601 Pennsylvania Avenue Nw
CiudadWASHINGTON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal20004
Teléfono12027562245
Sitio Webhttps://aspisotopes.com/
Símbolo de cotizaciónASPI
Fecha de salida a bolsaNov 10, 2022
Director ejecutivoAinscow (Robert)

Ejecutivos de ASP Isotopes Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul Elliot Mann
Mr. Paul Elliot Mann
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
9.33M
-2.69%
Mr. Paul Elliot Mann
Mr. Paul Elliot Mann
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
9.33M
-2.69%
Mr. Robert Ainscow
Mr. Robert Ainscow
Co-Founder, Chief Operating Officer
Co-Founder, Chief Operating Officer
2.25M
-1.49%
Mr. Robert Ainscow
Mr. Robert Ainscow
Co-Founder, Chief Operating Officer
Co-Founder, Chief Operating Officer
2.25M
-1.49%
Ms. Heather Kiessling
Ms. Heather Kiessling
Chief Financial Officer
Chief Financial Officer
1.53M
-1.52%
Ms. Heather Kiessling
Ms. Heather Kiessling
Chief Financial Officer
Chief Financial Officer
1.53M
-1.52%
Dr. Duncan Moore, Ph.D.
Dr. Duncan Moore, Ph.D.
Independent Director
Independent Director
1.04M
-1.11%
Dr. Duncan Moore, Ph.D.
Dr. Duncan Moore, Ph.D.
Independent Director
Independent Director
1.04M
-1.11%
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
672.25K
-14.88%
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
672.25K
-14.88%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul Elliot Mann
Mr. Paul Elliot Mann
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
9.33M
-2.69%
Mr. Paul Elliot Mann
Mr. Paul Elliot Mann
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
9.33M
-2.69%
Mr. Robert Ainscow
Mr. Robert Ainscow
Co-Founder, Chief Operating Officer
Co-Founder, Chief Operating Officer
2.25M
-1.49%
Mr. Robert Ainscow
Mr. Robert Ainscow
Co-Founder, Chief Operating Officer
Co-Founder, Chief Operating Officer
2.25M
-1.49%
Ms. Heather Kiessling
Ms. Heather Kiessling
Chief Financial Officer
Chief Financial Officer
1.53M
-1.52%
Ms. Heather Kiessling
Ms. Heather Kiessling
Chief Financial Officer
Chief Financial Officer
1.53M
-1.52%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de ASP Isotopes Inc?

Los cinco principales accionistas de ASP Isotopes Inc son: Mr. Paul Elliot Mann

¿Cuántas instituciones poseen acciones de ASP Isotopes Inc (ASPI)?

A fecha de 2026Q1, 345 instituciones poseen acciones de ASP Isotopes Inc, con un valor de mercado combinado de aproximadamente 73.95M, lo que representa el 58.74% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 11377644.00.
tradingkey.logo
Advertencia de Riesgo: Nuestro sitio web y aplicación móvil solo proporcionan información general sobre ciertos productos de inversión. Finsights no proporciona, y la provisión de dicha información no debe interpretarse como que Finsights proporciona, asesoramiento financiero o recomendación para cualquier producto de inversión.
Los productos de inversión están sujetos a riesgos de inversión significativos, incluida la posible pérdida del monto principal invertido y pueden no ser adecuados para todos. El rendimiento pasado de los productos de inversión no es indicativo de su rendimiento futuro.
Finsights puede permitir que anunciantes o afiliados de terceros coloquen o entreguen anuncios en nuestro sitio web o aplicación móvil o en cualquier parte de los mismos y puede ser compensado por ellos en función de su interacción con los anuncios.
© Derechos de autor: FINSIGHTS MEDIA PTE. LTD. Todos los derechos reservados.